TMEM16A Channel Blockade and Strontium/ROS Regulation by Carrier‐Free Nanoprodrug to Reconstruct Bone Homeostasis for Enhanced Osteoporosis Prevention and Treatment
Donghong Shi(Hebei University of Technology), Hailong An(Hebei University of Technology)
Cited by 1
Related Papers
CXCL5 activates CXCR2 in nociceptive sensory neurons to drive joint pain and inflammation in experimental gouty arthritis
|Nature Communications|2024|62
TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment
|International Journal of Molecular Sciences|2021|34